ACP Journal Club. Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia.
Patel
Tejas V
TV
Brigham and Women's Hospital, Boston, Massachusetts, USA.